BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12210777)

  • 21. 3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors.
    Szekeres HJ; Atack JR; Chambers MS; Cook SM; Macaulay AJ; Pillai GV; MacLeod AM
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2871-5. PubMed ID: 15125950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and benzodiazepine receptor affinity of derivatives of the new tricyclic heteroaromatic system pyrido[3',2':5,6]thiopyrano[4,3-c]pyridazin-3(2H,5H)-one.
    Primofiore G; Da Settimo F; Marini AM; Simorini F; La Motta C; Taliani S; Laneri S; Trincavelli L; Martini C
    Arch Pharm (Weinheim); 2005 Mar; 338(2-3):126-32. PubMed ID: 15799013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structure-activity relationships at the GABA(A) receptor in rat brain, and differential electrophysiological profile at the recombinant human GABA(A) receptor of a series of substituted 1,2-diphenylimidazoles.
    Asproni B; Talani G; Busonero F; Pau A; Sanna S; Cerri R; Mascia MP; Sanna E; Biggio G
    J Med Chem; 2005 Apr; 48(7):2638-45. PubMed ID: 15801854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient synthesis and biological evaluation of 1,2,9-trisubstituted 1,9-dihydro-6H-purin-6-ones.
    Huang NY; Liang YJ; Ding MW; Fu LW; He HW
    Bioorg Med Chem Lett; 2009 Feb; 19(3):831-3. PubMed ID: 19117758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alkylene tether-length dependent gamma-aminobutyric acid type A receptor competitive antagonism by tacrine dimers.
    Li C; Carlier PR; Ren H; Kan KK; Hui K; Wang H; Li W; Li Z; Xiong K; Clement EC; Xue H; Liu X; Li M; Pang Y; Han Y
    Neuropharmacology; 2007 Feb; 52(2):436-43. PubMed ID: 17056074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptor.
    Mitchinson A; Atack JR; Blurton P; Carling RW; Castro JL; Curley KS; Russell MG; Marshall G; McKernan RM; Moore KW; Narquizian R; Smith A; Street LJ; Thompson SA; Wafford K
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3441-4. PubMed ID: 15177449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain.
    Ahboucha S; Araqi F; Layrargues GP; Butterworth RF
    Neurochem Int; 2005 Jul; 47(1-2):58-63. PubMed ID: 15913842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CNS 7056: a novel ultra-short-acting Benzodiazepine.
    Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
    Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modeling.
    Lager E; Andersson P; Nilsson J; Pettersson I; Nielsen EØ; Nielsen M; Sterner O; Liljefors T
    J Med Chem; 2006 Apr; 49(8):2526-33. PubMed ID: 16610795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepine receptor ligands. 8: synthesis and pharmacological evaluation of new pyrazolo[5,1-c] [1,2,4]benzotriazine 5-oxide 3- and 8-disubstituted: high affinity ligands endowed with inverse-agonist pharmacological efficacy.
    Guerrini G; Costanzo A; Ciciani G; Bruni F; Selleri S; Costagli C; Besnard F; Costa B; Martini C; De Siena G; Malmberg-Aiello P
    Bioorg Med Chem; 2006 Feb; 14(3):758-75. PubMed ID: 16214350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and cardiovascular activity of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3- piperazinopropyl)-3,7-dihydro-1H-purine-2,6-diones.
    Chłoń-Rzepa G; Pawłowski M; Zygmunt M; Filipek B; Maciag D
    Pol J Pharmacol; 2004; 56(6):755-66. PubMed ID: 15662088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as novel, highly potent, and safe antianxiety agent.
    Anzini M; Braile C; Valenti S; Cappelli A; Vomero S; Marinelli L; Limongelli V; Novellino E; Betti L; Giannaccini G; Lucacchini A; Ghelardini C; Norcini M; Makovec F; Giorgi G; Ian Fryer R
    J Med Chem; 2008 Aug; 51(15):4730-43. PubMed ID: 18637672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists.
    Baraldi PG; Preti D; Tabrizi MA; Romagnoli R; Saponaro G; Baraldi S; Botta M; Bernardini C; Tafi A; Tuccinardi T; Martinelli A; Varani K; Borea PA
    Bioorg Med Chem; 2008 Dec; 16(24):10281-94. PubMed ID: 19006671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology.
    Krehan D; Storustovu SI; Liljefors T; Ebert B; Nielsen B; Krogsgaard-Larsen P; Frølund B
    J Med Chem; 2006 Feb; 49(4):1388-96. PubMed ID: 16480274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, biological testing, and binding mode prediction of 6,9-diarylpurin-8-ones as p38 MAP kinase inhibitors.
    Hauser DR; Scior T; Domeyer DM; Kammerer B; Laufer SA
    J Med Chem; 2007 May; 50(9):2060-6. PubMed ID: 17411025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor.
    Primofiore G; Da Settimo F; Taliani S; Simorini F; Patrizi MP; Novellino E; Greco G; Abignente E; Costa B; Chelli B; Martini C
    J Med Chem; 2004 Mar; 47(7):1852-5. PubMed ID: 15027878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivities of benzodiazepine receptor binding and muscarinic acetylcholine receptor binding for the detection of neural cell death caused by sodium nitroprusside microinjection in rat brain.
    Inoue O; Yanamoto K; Fujiwara Y; Hosoi R; Kobayashi K; Tsukada H
    Synapse; 2003 Aug; 49(2):134-41. PubMed ID: 12740869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and structure-activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands.
    Okubo T; Yoshikawa R; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2004 Jul; 12(13):3569-80. PubMed ID: 15186841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
    Atack JR; Alder L; Cook SM; Smith AJ; McKernan RM
    Neuropharmacology; 2005 Aug; 49(2):220-9. PubMed ID: 15996568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.